Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin: 2017-2025

Historic Net Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to 9.63%.

  • Organogenesis Holdings' Net Margin fell 108.00% to 9.63% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.88%, marking a year-over-year decrease of 126.00%. This contributed to the annual value of -0.19% for FY2024, which is 134.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its Net Margin stood at 9.63% for Q3 2025, which was up 179.70% from -12.08% recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Net Margin high stood at 39.88% for Q4 2021, and its period low was -24.91% during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Net Margin value was -0.57% (recorded in 2023), while the average stood at -2.08%.
  • In the last 5 years, Organogenesis Holdings' Net Margin skyrocketed by 3,612bps in 2021 and then tumbled by 3,340bps in 2022.
  • Organogenesis Holdings' Net Margin (Quarterly) stood at 39.88% in 2021, then crashed by 3,340bps to 6.48% in 2022, then plummeted by 705bps to -0.57% in 2023, then soared by 521bps to 4.64% in 2024, then plummeted by 108bps to 9.63% in 2025.
  • Its Net Margin was 9.63% in Q3 2025, compared to -12.08% in Q2 2025 and -24.91% in Q1 2025.